Coacervation-Driven Semipermeable Nanoreactors for Enzymatic Cascade-Mediated Cancer Combination Therapy with Enhanced Efficacy

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - (2024) vom: 05. Sept., Seite e2407378
1. Verfasser: Lin, Min (VerfasserIn)
Weitere Verfasser: Lv, Xueli, Wang, Hepeng, Shu, Lilei, Wang, Helin, Zhang, Guojing, Sun, Jing, Chen, Xuesi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article cancer combination therapy coacervation enzymatic cascade nanoreactors semipermeable
LEADER 01000naa a22002652 4500
001 NLM377224855
003 DE-627
005 20240905233842.0
007 cr uuu---uuuuu
008 240905s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202407378  |2 doi 
028 5 2 |a pubmed24n1524.xml 
035 |a (DE-627)NLM377224855 
035 |a (NLM)39235373 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Lin, Min  |e verfasserin  |4 aut 
245 1 0 |a Coacervation-Driven Semipermeable Nanoreactors for Enzymatic Cascade-Mediated Cancer Combination Therapy with Enhanced Efficacy 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 05.09.2024 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
520 |a © 2024 Wiley‐VCH GmbH. 
520 |a Utilizing enzyme cascades as a promising approach for targeted cancer therapies holds significant potential, yet its clinical effectiveness is substantially hindered by functional losses during delivery. Complex coacervation emerges as an intriguing strategy for designing functional nanoreactors. In this study, a noteworthy achievement is presented in the development of lactobionic acid-modified tumor microenvironment (TME)-responsive polyelectrolyte complex vesicles (HGS-PCVs) based on bioinspired homopolypeptoids, which serve as a facile, intelligent, and highly efficient nanoreactor tunable for glucose oxidase, hemoglobin, and sorafenib (SRF) to hepatic cancer cells. The TME-responsive permeability of HGS-PCVs enables the selective entry of glucose into their interior, triggering an enzymatic cascade reaction within the tumor. This intricate process generates toxic hydroxyl radicals while concurrently lowering the pH. Consequently, this pH shift enhances the SRF release, effectively promoting ferroptosis and apoptosis in the target cancer cells. Further, the administration of the HGS-PCVs not only initiates immunogenic cell death but also plays a crucial role in inducing the maturation of dendritic cells within lymph nodes. It stimulates an adaptive T-cell response, a crucial mechanism that contributes to impeding the growth of distant tumors in vivo, demonstrating the promising potential of PCVs for cancer immunotherapy 
650 4 |a Journal Article 
650 4 |a cancer combination therapy 
650 4 |a coacervation 
650 4 |a enzymatic cascade 
650 4 |a nanoreactors 
650 4 |a semipermeable 
700 1 |a Lv, Xueli  |e verfasserin  |4 aut 
700 1 |a Wang, Hepeng  |e verfasserin  |4 aut 
700 1 |a Shu, Lilei  |e verfasserin  |4 aut 
700 1 |a Wang, Helin  |e verfasserin  |4 aut 
700 1 |a Zhang, Guojing  |e verfasserin  |4 aut 
700 1 |a Sun, Jing  |e verfasserin  |4 aut 
700 1 |a Chen, Xuesi  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g (2024) vom: 05. Sept., Seite e2407378  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g year:2024  |g day:05  |g month:09  |g pages:e2407378 
856 4 0 |u http://dx.doi.org/10.1002/adma.202407378  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 2024  |b 05  |c 09  |h e2407378